Successful Treatment of Sacral Pressure Injury With ACU-D1

Area of Science:

• Dermatology
• Wound Healing
• Pharmacology

Background:

• Pressure injuries, or pressure ulcers, frequently impact the sacral area in elderly patients.
• Standard treatment involves supportive care, primarily pressure avoidance.
• A stage 2 sacral pressure injury in a case report showed resistance to conventional therapy for one month.

Purpose of the Study:

• To report a case of successful treatment of a refractory sacral pressure injury.
• To investigate the efficacy of ACU-D1, a proteasome inhibitor cream, in wound healing.

Main Methods:

• A patient with a stage 2 sacral pressure injury received a trial of 10% ACU-D1 cream.
• Treatment outcomes were monitored over a one-month period.

Main Results:

• The patient experienced symptom relief and complete re-epithelialization of the pressure injury within one month of ACU-D1 application.
• The proteasome inhibitor cream demonstrated significant efficacy in healing the resistant wound.

Conclusions:

• ACU-D1 may be a promising therapeutic agent for treating pressure injuries and other chronic wounds.
• The findings suggest a potential role for proteasome inhibitors in wound management, possibly by modulating inflammation and neutrophil activity.